With the world experiencing three major health crises in the past decade – severe acute respiratory syndrome, H1N1 pandemic influenza and Ebola – and the potential for other emerging diseases to turn into an epidemic, such as the Middle East respiratory syndrome coronavirus (MERS-CoV), there's a critical need for the rapid evaluation of experimental therapies, US officials said, laying out their argument in an Aug. 5 Perspectives article in the New England Journal of Medicine.
"The serious impact of these emergencies and the lack of effective therapies warrant moving forward with clinical testing as soon...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?